Cargando…

H3 K27-altered diffuse midline glioma in adults arising from atypical regions: Two case reports and literature review

Diffuse midline glioma (DMG), H3 K27-altered, is a newly defined “pediatric-type,” diffuse, high-grade glioma under current WHO classifications (updated in 2021). An essential diagnostic criteria of DMG is its occurrence in the midline structures; most intracranial DMG occurs in the brainstem or tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugii, Narushi, Ninomiya, Yuki, Akimoto, Yu, Tsurubuchi, Takao, Ishikawa, Eiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651424/ https://www.ncbi.nlm.nih.gov/pubmed/38028289 http://dx.doi.org/10.1016/j.radcr.2023.10.031

Ejemplares similares

Acute cerebral hemorrhage mimicking glioblastoma on intraoperative magnetic resonance imaging: A case report
por: Miyamoto, Satoshi, et al.
Publicado: (2023)

Spinal cord diffuse midline glioma with postoperative acute swelling: A case report and review of literature
por: Karita, Hiroki, et al.
Publicado: (2023)

Sclerosing meningioma with a large peritumoral cyst: Case report
por: Sugii, Narushi, et al.
Publicado: (2023)

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
por: Zhao, Ji-ping, et al.
Publicado: (2022)

Frontal sinus giant osteoma with radiologically unusual component suggesting blood supply: A case report
por: Watanabe, Noriyuki, et al.
Publicado: (2022)

DIPG-42. Diffuse midline gliomas, H3K27-altered as an interdisciplinary challenge
por: Kammler, Gertrud, et al.
Publicado: (2022)

DIPG-44. H3K27-altered diffuse midline gliomas with secondary driver molecular alterations
por: Gestrich, Catherine, et al.
Publicado: (2022)

Fatal Postpartum Hemorrhage in Diffuse Midline Glioma with H3-K27M Mutation
por: Miyazaki, Takeshi, et al.
Publicado: (2019)

Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration
por: Huang, Bowen, et al.
Publicado: (2023)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis
por: Ishikawa, Eiichi, et al.
Publicado: (2021)

P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients
por: Yamada, Erika, et al.
Publicado: (2023)

IM-6 HVJ-E containing PD-L1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma
por: Sugii, Narushi, et al.
Publicado: (2021)

Case Report: Five Adult Cases of H3K27-Altered Diffuse Midline Glioma in the Spinal Cord
por: Gu, Quanquan, et al.
Publicado: (2021)

DIPG-51. ABDOMINAL METASTASES OF DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED WITH A VENTRICULOPERITONEAL SHUNT
por: Lazow, Margot, et al.
Publicado: (2023)

Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

Radiotherapy and radio‐sensitization in H3 (K27M) ‐mutated diffuse midline gliomas
por: Liu, Chao, et al.
Publicado: (2023)

A H3K27M-targeted vaccine in adults with diffuse midline glioma
por: Grassl, Niklas, et al.
Publicado: (2023)

Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time
por: Power, Erica A, et al.
Publicado: (2023)

Diffuse midline glioma, H3K27-altered, of the conus medullaris presenting as acute urinary retention: illustrative case
por: Saluja, Sabir, et al.
Publicado: (2023)

CEREBELLAR DIFFUSE MIDLINE GLIOMA, H3K27M ALTERED IN A FIFTY-FIVE-YEAR-OLD PATIENT
por: Ibdah, Haleem, et al.
Publicado: (2023)

Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas
por: Raab, Peter, et al.
Publicado: (2022)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
por: Banan, Rouzbeh, et al.
Publicado: (2017)

Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas
por: Welby, John P., et al.
Publicado: (2019)

Morphological Spectrum and Survival Analysis of Diffuse Midline Glioma With H3K27M Mutation
por: Hassan, Usman, et al.
Publicado: (2021)

Diffuse midline glioma H3K27M mutation in adult: A case report
por: Bhattarai, Ayush Mohan, et al.
Publicado: (2022)

Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman
por: Low, Justin Thomas, et al.
Publicado: (2021)

Perioperative Deep Vein Thrombosis and D-dimer Measurement in Patients with Brain Tumor
por: OKAMOTO, Emiko, et al.
Publicado: (2022)

A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis
por: Aftahy, A. Kaywan, et al.
Publicado: (2023)

Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review
por: De Martino, Lucia, et al.
Publicado: (2023)

Deep learning‐based prediction of H3K27M alteration in diffuse midline gliomas based on whole‐brain MRI
por: Huang, Bowen, et al.
Publicado: (2023)

Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
por: Miyazaki, Tsubasa, et al.
Publicado: (2020)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020)

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
por: Wingerter, Arthur, et al.
Publicado: (2021)

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
por: Majzner, Robbie G., et al.
Publicado: (2022)

A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
por: Peng, Youheng, et al.
Publicado: (2023)

Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma
por: Sugii, Narushi, et al.
Publicado: (2020)

Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures
por: Banan, Rouzbeh, et al.
Publicado: (2021)

Convergent evolution and multi-wave clonal invasion in H3 K27-altered diffuse midline gliomas treated with a PDGFR inhibitor
por: Arunachalam, Sasi, et al.
Publicado: (2022)

HGG-31. Unique case of a bithalamic H3K27-wildtype diffuse midline glioma, EGFR-altered with methylated MGMT
por: Reinecke, James, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tjn2s32baoacno51snjcm9grb